Literature DB >> 30559054

Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra-individually controlled, phase III trial with 12-months follow-up.

Quentin Frew1, Hans-Oliver Rennekampff2, Peter Dziewulski1, Naiem Moiemen3, Tobias Zahn4, Bernd Hartmann5.   

Abstract

OBJECTIVE: Acceleration of wound healing promises advantages for patients and caregivers in reducing the burden of disease, avoiding complications such as wound infections, and improving the long-term outcome. However, medicines that can accelerate wound healing are lacking. The objective of this open, blindly evaluated, randomized, multicenter phase III study was to compare intra-individually the efficacy and tolerability of Oleogel-S10 with fatty gauze dressing versus Octenilin® wound gel with fatty gauze dressing in accelerating the healing of superficial partial thickness burn wounds.
METHODS: Acute superficial partial thickness burn wounds in adults caused by fire, heat burn or scalding were divided into 2 halves and randomly assigned to treatment with Oleogel-S10 or Octenilin® wound gel. Photos for observer-blinded analysis of wound healing were taken at each wound dressing change. Percentages of reepithelialization were assessed at defined intervals. Efficacy and tolerability were evaluated based on a 5-point Likert scale.
RESULTS: Of 61 patients that were enrolled, 57 received the allocated intervention and 48 completed treatment. The percentage of patients with earlier wound healing was significantly higher for Oleogel-S10 (85.7%, n=30) compared to Octenilin® wound gel (14.3%, n=5, p<0.0001). The mean intra-individual difference in time to wound closure was -1.0 day in favour of Oleogel-S10 (-1.4, -0.6; 95% CI, p<0.0001). Most investigators (87.0%) and patients (84.8%) evaluated the efficacy of Oleogel-S10 to be 'better' or 'much better' than that of Octenilin® wound gel. Long-term outcome 3 months and 12 months post injury was improved in some patients.
CONCLUSIONS: Oleogel-S10 (Episalvan) significantly accelerated the healing of superficial partial thickness burn wounds. It was safe and well tolerated.
Copyright © 2018 Elsevier Ltd and ISBI. All rights reserved.

Entities:  

Keywords:  Betulin; Birch bark extract; Grade 2a burns; Partial thickness wounds; Randomized clinical trial; Superficial partial thickness burns

Year:  2018        PMID: 30559054     DOI: 10.1016/j.burns.2018.10.019

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  9 in total

Review 1.  Drug Candidates for Autoimmune Diseases.

Authors:  Sabrina Saurin; Myriam Meineck; Gerhard Erkel; Till Opatz; Julia Weinmann-Menke; Andrea Pautz
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-20

Review 2.  Botanical Drugs in Traditional Chinese Medicine With Wound Healing Properties.

Authors:  Shuyi Ning; Jie Zang; Bingyang Zhang; Xinchi Feng; Feng Qiu
Journal:  Front Pharmacol       Date:  2022-05-12       Impact factor: 5.988

Review 3.  Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa.

Authors:  Allison R Keith; Kirk Twaroski; Christen L Ebens; Jakub Tolar
Journal:  Expert Opin Biol Ther       Date:  2020-03-20       Impact factor: 4.388

4.  Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationale.

Authors:  Johannes S Kern; Agnes Schwieger-Briel; Sandra Löwe; Mark Sumeray; Charles Davis; Anna E Martinez
Journal:  Trials       Date:  2019-06-11       Impact factor: 2.279

Review 5.  Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa.

Authors:  Agnes Schwieger-Briel; Hagen Ott; Dimitra Kiritsi; Melanie Laszczyk-Lauer; Christine Bodemer
Journal:  Dermatol Ther       Date:  2019-07-02       Impact factor: 2.851

Review 6.  Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.

Authors:  Verena Wally; Manuela Reisenberger; Sophie Kitzmüller; Martin Laimer
Journal:  Orphanet J Rare Dis       Date:  2020-10-19       Impact factor: 4.123

Review 7.  Anti-Inflammatory and Anticancer Properties of Birch Bark-Derived Betulin: Recent Developments.

Authors:  Hardeep Singh Tuli; Katrin Sak; Dhruv Sanjay Gupta; Ginpreet Kaur; Diwakar Aggarwal; Nidarshana Chaturvedi Parashar; Renuka Choudhary; Mukerrem Betul Yerer; Jagjit Kaur; Manoj Kumar; Vivek Kumar Garg; Gautam Sethi
Journal:  Plants (Basel)       Date:  2021-12-03

8.  Zinc Oxide Nanoparticles Protected with Terpenoids as a Substance in Redox Imbalance Normalization in Burns.

Authors:  Nina Melnikova; Alyona Balakireva; Dmitry Orekhov; Denis Kamorin; Natalia Didenko; Darina Malygina; Alexander Knyazev; Denis Novopoltsev; Anna Solovyeva
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-21

9.  Preparation and Characterization of Electrospun Polylactic Acid (PLA) Fiber Loaded with Birch Bark Triterpene Extract for Wound Dressing.

Authors:  Tianyuan Fan; Rolf Daniels
Journal:  AAPS PharmSciTech       Date:  2021-07-20       Impact factor: 3.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.